126 related articles for article (PubMed ID: 2645364)
1. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
Dankert JR
J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
[TBL] [Abstract][Full Text] [Related]
2. Complement attack of altered outer membrane areas synthesized after inhibition of the 3-deoxy-D-manno-octulosonate pathway leads to cell death.
Goldman RC; Miller MF
J Immunol; 1989 Jan; 142(1):185-94. PubMed ID: 2535855
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
4. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites.
MacKay SL; Dankert JR
J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122
[TBL] [Abstract][Full Text] [Related]
5. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
6. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
Li YP; Mold C; Du Clos TW
J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
[TBL] [Abstract][Full Text] [Related]
7. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
8. Beyond lysis: how complement influences cell fate.
Cole DS; Morgan BP
Clin Sci (Lond); 2003 May; 104(5):455-66. PubMed ID: 12580763
[TBL] [Abstract][Full Text] [Related]
9. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
Halstead SK; O'Hanlon GM; Humphreys PD; Morrison DB; Morgan BP; Todd AJ; Plomp JJ; Willison HJ
Brain; 2004 Sep; 127(Pt 9):2109-23. PubMed ID: 15289269
[TBL] [Abstract][Full Text] [Related]
10. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
[TBL] [Abstract][Full Text] [Related]
11. Membrane vesiculation of Naegleria fowleri amoebae as a mechanism for resisting complement damage.
Toney DM; Marciano-Cabral F
J Immunol; 1994 Mar; 152(6):2952-9. PubMed ID: 8144894
[TBL] [Abstract][Full Text] [Related]
12. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
13. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
14. Cytolysis of nucleated cells by complement: inhibition of membrane-transmethylation enhances cell death by C5b-9.
Hänsch GM; Betz M; Shin ML
J Immunol; 1984 Mar; 132(3):1440-4. PubMed ID: 6693772
[TBL] [Abstract][Full Text] [Related]
15. How complement kills E. coli. II. The apparent two-hit nature of the lethal event.
Wright SD; Levine RP
J Immunol; 1981 Sep; 127(3):1152-6. PubMed ID: 7021676
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
17. Membrane attack complex of complement in dermatitis herpetiformis.
Dahl MV; Falk RJ; Carpenter R; Michael AF
Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
[TBL] [Abstract][Full Text] [Related]
18. Bacterial killing by complement requires direct anchoring of membrane attack complex precursor C5b-7.
Doorduijn DJ; Bardoel BW; Heesterbeek DAC; Ruyken M; Benn G; Parsons ES; Hoogenboom BW; Rooijakkers SHM
PLoS Pathog; 2020 Jun; 16(6):e1008606. PubMed ID: 32569291
[TBL] [Abstract][Full Text] [Related]
19. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.
Reiter Y; Ciobotariu A; Jones J; Morgan BP; Fishelson Z
J Immunol; 1995 Aug; 155(4):2203-10. PubMed ID: 7636268
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
